[Form 4] HOLOGIC INC Insider Trading Activity

Rhea-AI Filing Summary

Hologic, Inc. insider reports tax-related share withholding

A Hologic executive, identified as President, Diagnostic Solutions, reported a routine equity transaction involving company common stock. On 11/14/2025, 561 shares of Hologic common stock were disposed of at $74.15 per share under transaction code “F,” which indicates shares were withheld to cover tax obligations upon settlement of previously granted restricted stock units whose service-based vesting conditions had been met. After this transaction, the executive beneficially owns 41,318 shares of Hologic common stock in direct ownership. No derivative securities transactions were reported in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schneiders Jennifer M

(Last) (First) (Middle)

250 CAMPUS DRIVE

(Street)

MARLBOROUGH MA 01752

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Diag. Solutions

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/14/2025		F		561(1)	D	$74.15	41,318	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied.

	/s/ Mark W. Irving, attorney-in-fact for Ms. Schneiders	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction at Hologic (HOLX) is disclosed in this Form 4?

The filing reports that a Hologic executive disposed of 561 shares of Hologic common stock on 11/14/2025 in a routine transaction related to tax withholding on vested restricted stock units.

At what price were the Hologic (HOLX) shares disposed of in this Form 4?

The 561 shares of Hologic common stock were disposed of at a price of $74.15 per share in connection with tax withholding on vested restricted stock units.

How many Hologic (HOLX) shares does the reporting person own after the transaction?

Following the reported transaction, the executive beneficially owns 41,318 shares of Hologic common stock, held in direct ownership.

What is the reason for the share disposal reported for Hologic (HOLX)?

The filing explains that the 561 shares were withheld for tax obligations in connection with the settlement of restricted stock units whose service-based vesting requirements had been satisfied.

Does this Hologic (HOLX) Form 4 report any derivative securities activity?

The Form 4 includes a section for derivative securities but shows no derivative securities acquired or disposed of in the reported transaction.

What is the reporting person’s relationship to Hologic (HOLX)?

The reporting person is an officer of Hologic, serving as President, Diagnostic Solutions, and is filing as a single reporting person.